Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion type Assertion NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_head.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion description "[The use of reverse-transcription polymerase chain reaction (RT-PCR) for the detection of the PML-RARA and RARA-PML fusion genes is the only technique that defines the PML breakpoint type and that allows the definition of a correct strategy for subsequent minimal residual disease (MRD) monitoring.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion evidence source_evidence_literature NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion SIO_000772 16502581 NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion wasDerivedFrom befree-20140225 NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion wasGeneratedBy ECO_0000203 NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.